C91.Z2
Other lymphoid leukemia, in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Other lymphoid leukemia in relapse, classified under ICD-10 code C91.Z2, is a form of leukemia that affects the lymphoid cells—white blood cells involved in the immune response. This condition occurs when a previously diagnosed lymphoid leukemia recurs after treatment, indicating a relapse. It is a serious health condition requiring ongoing medical management. This article provides a patient-friendly overview of what this diagnosis entails, including potential causes, common symptoms, diagnostic procedures, and general treatment approaches.
Causes & Symptoms
Clinical Causes: Genetic mutations in lymphoid cells Previous exposure to radiation or certain chemotherapy drugs Family history of leukemia or other blood disorders Environmental exposures to chemicals such as benzene Immune system deficiencies or certain inherited disorders
Key Symptoms: Fatigue and weakness Unintended weight loss Fever or night sweats Easy bruising or bleeding Frequent infections Swollen lymph nodes, especially in the neck, armpits, or groin Bone or joint pain Shortness of breath or cough if the lungs are involved
Diagnostic & Treatment
Diagnosis Path: Blood tests to measure blood cell counts and look for abnormal cells Bone marrow biopsy to examine marrow cells Flow cytometry to identify specific cell markers Cytogenetic and molecular tests to detect genetic abnormalities Imaging studies like CT scans or ultrasounds may be used to evaluate lymph nodes and organs
Treatment Protocols: Chemotherapy to kill or control abnormal lymphoid cells Targeted therapy that specifically attacks cancer cells based on genetic markers Immunotherapy to boost the body's immune response against the leukemia Stem cell or bone marrow transplantation in certain cases Supportive care such as antibiotics, blood transfusions, or growth factors to manage symptoms and prevent infections
Clinical Advice & FAQs
Billing Guidance
Is C91.Z2 a billable ICD-10 code?
Yes, C91.Z2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C91.Z2?
Clinical documentation must specify the nature of Other lymphoid leukemia, in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference